The peptide market in the U.S. is experiencing rapid growth, and cryptocurrency is becoming a key driver of this process. In the first quarter of 2026, sellers of such drugs received $32 million in digital assets, demonstrating a staggering year-over-year growth of 700%. This is not just statistics — it is a clear signal of structural changes in consumer behavior and payment infrastructure.

Why Bitcoin, Not Visa

Peptides, promoted as means for weight loss, muscle gain, and rejuvenation, have become the subject of active online trading. However, a significant portion of this market bypasses traditional channels. Banks and card networks refuse to service sellers due to high compliance risks associated with unregulated substances. As a result, suppliers are forced to switch to Bitcoin. For many buyers, this becomes their first experience using cryptocurrency.

Here is a typical example: a 49-year-old marketing director from the U.S., looking for retatrutide (an Eli Lilly drug), found a Chinese supplier who agreed to send 20 vials for $240. In the U.S. market, such a purchase would have cost him $300 monthly. The seller only accepted digital assets, and the buyer had to buy Bitcoin for the first time in his life.

Three Stages of Explosive Growth

Analysis of on-chain data allows us to identify three key stages in the evolution of this market. Before 2025, it was a niche "underground" with a monthly inflow of about $200,000. Then the topic came to the attention of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the U.S. Department of Health and Human Services. Although a direct causal link is not traceable through blockchain data, the coincidence is obvious.

The real explosion occurred in late 2025, when the topic infiltrated the TikTok subculture of looksmaxxing — a community obsessed with improving appearance. The average monthly inflow quadrupled to $9.9 million, and in peak months exceeded $10 million. This is a classic example of how viral content can instantly reshape demand structure.

Major Players Choose Stablecoins

The market is unevenly structured. The bulk of the volume comes from a narrow group of large sellers with a broad client base. The larger the supplier, the more professional their transactions. Small players dabble in various coins, but large ones — almost exclusively Bitcoin and stablecoins. Sellers with an average deposit of $1,000 or more predominantly use "stablecoins," allowing them to hedge volatility in large and cross-border purchases.

The Chinese Connection and Shadow Economy

The primary raw materials for peptides are produced in China. Over three quarters of 2025, imports from China to the U.S. doubled to over $300 million. Notably, some suppliers have transitioned to peptides from the drug business. For example, the Chinese company Bigreat Technology, which previously supplied precursors for fentanyl and amphetamines to markets in Russia and Kazakhstan, created a separate legal entity — Zhengzhou DEPU Technology — to sell cosmetic peptides.

Experts at TRM Labs compare the dynamics of this market to the early stages of shadow online markets like Silk Road. And this comparison is not without merit: we are witnessing the formation of a new parallel economy, where cryptocurrency becomes not just a tool but a foundation for cross-border trade bypassing traditional regulators.

My comment: This case is a vivid illustration of how cryptocurrencies fill the vacuum created by the inefficiency of traditional payment systems. The peptide market demonstrates that even for "gray" zones, there is enormous unmet demand that blockchain technology can serve with minimal costs. However, regulators should think: if they cannot offer legal alternatives, the shadow economy will only grow, and Bitcoin will become its standard means of payment.